Caricamento...
Systematic assessment of HER2/neu in gynecologic neoplasms, an institutional experience
BACKGROUND: HER2/neu overexpression and/or amplification has been widely studied in a number of solid tumors, primarily in the breast. In gynecologic neoplasms, determination of HER2/neu status has not been well studied as a predictive biomarker in anti-HER2/neu treatment. METHODS: We systematically...
Salvato in:
| Pubblicato in: | Diagn Pathol |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BioMed Central
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5075405/ https://ncbi.nlm.nih.gov/pubmed/27770810 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13000-016-0553-8 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|